Emily Weyburne

Post-Doctoral Fellow, Dartmouth College


  • PhD '16, Cancer Biology and Molecular Therapeutics, Dartmouth College
  • BA, Colgate University

Selected Publications

  • Kraus M, Bader J, Geurink PP, Weyburne ES, Mirabella AC, Silzle T, Shabaneh TB, van der Linden WA, de Bruin G, Haile SR, van Rooden E, Appenzeller C, Li N, Kisselev AF, Overkleeft H, Driessen C. The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells. Haematologica. 2015;100:1350-60.

  • Wilkins OM, Downey SL, Weyburne ES, Williams DA, Mirabella AC, Overkleeft HS, Kisselev AF. Cell-line-specific high background in the Proteasome-Glo assay of proteasome trypsin-like activity. Anal Biochem. 2014; 451:1-3.


Best Poster award at 2015 Molecular Therapeutics of Cancer Research Conference meeting

Best Poster award at 2015 New England Shared Resources Conference meeting

Excellence for Journal Club Award April 2015